UNI-MB - logo
UMNIK - logo
 
E-viri
Celotno besedilo
Recenzirano
  • New DyeVert system for cont...
    Tarantini, Giuseppe; Cardaioli, Francesco

    Catheterization and cardiovascular interventions, July 1, 2021, 2021-07-00, 20210701, Letnik: 98, Številka: 1
    Journal Article

    Key Points CI‐AKI is an iatrogenic renal damage that can occur in patients undergoing percutaneous procedures with the use of contrast media. This article tested the efficacy and safety of the new DyeVert system, demonstrating a significant reduction in CM volume injected and in the incidence of post‐procedural CI‐AKI. Future researches will be needed to confirm these results and identify the specific type of patient in which a reduction in CM volume would impact in clinical outcomes.